THYMOSIN-BETA-SULPHOXIDE AS AN IMMUNOSUPPRESSIVE ACTIVE AGENT

摘要

The invention provides the use of thymosin beta-4 sulphoxide in the preparation of an immunosuppressant for prevention and/or treatment of lymphocyte-mediated organ or bone marrow transplant rejection. The invention also provides the use of thymosin beta-4 sulphoxide in the preparation of an immunosuppressant for the treatment of lymphocyte-mediated graft-versus-host disease.